A Phase II Trial of the Safety, Local Tolerability, and Efficacy of EcoNail™ (Econazole 5%/SEPA® 18% Nail Lacquer) in Onychomycosis of the Great Toenail
Latest Information Update: 04 Sep 2020
At a glance
- Drugs Econazole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Abeona therapeutics; MacroChem
- 01 Sep 2020 Status changed from active, no longer recruiting to completed.
- 03 Jun 2014 New trial record